Corvus Pharmaceuticals (CRVS) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $2.9 million.
- Corvus Pharmaceuticals' Cash & Current Investments fell 3873.93% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 3873.93%. This contributed to the annual value of $8.7 million for FY2024, which is 3074.48% down from last year.
- Latest data reveals that Corvus Pharmaceuticals reported Cash & Current Investments of $2.9 million as of Q3 2025, which was down 3873.93% from $14.7 million recorded in Q2 2025.
- Corvus Pharmaceuticals' 5-year Cash & Current Investments high stood at $31.5 million for Q1 2022, and its period low was $2.9 million during Q3 2025.
- In the last 4 years, Corvus Pharmaceuticals' Cash & Current Investments had a median value of $12.6 million in 2023 and averaged $13.7 million.
- Examining YoY changes over the last 5 years, Corvus Pharmaceuticals' Cash & Current Investments showed a top increase of 9379.73% in 2024 and a maximum decrease of 7672.22% in 2024.
- Over the past 4 years, Corvus Pharmaceuticals' Cash & Current Investments (Quarter) stood at $13.2 million in 2022, then dropped by 4.1% to $12.6 million in 2023, then plummeted by 30.74% to $8.7 million in 2024, then crashed by 67.2% to $2.9 million in 2025.
- Its Cash & Current Investments was $2.9 million in Q3 2025, compared to $14.7 million in Q2 2025 and $5.0 million in Q1 2025.